1. Home
  2. TXMD vs HUBC Comparison

TXMD vs HUBC Comparison

Compare TXMD & HUBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TXMD
  • HUBC
  • Stock Information
  • Founded
  • TXMD 2008
  • HUBC 2017
  • Country
  • TXMD United States
  • HUBC Israel
  • Employees
  • TXMD N/A
  • HUBC N/A
  • Industry
  • TXMD Biotechnology: Pharmaceutical Preparations
  • HUBC
  • Sector
  • TXMD Health Care
  • HUBC
  • Exchange
  • TXMD Nasdaq
  • HUBC Nasdaq
  • Market Cap
  • TXMD 12.8M
  • HUBC 15.2M
  • IPO Year
  • TXMD N/A
  • HUBC N/A
  • Fundamental
  • Price
  • TXMD $1.00
  • HUBC $1.11
  • Analyst Decision
  • TXMD
  • HUBC
  • Analyst Count
  • TXMD 0
  • HUBC 0
  • Target Price
  • TXMD N/A
  • HUBC N/A
  • AVG Volume (30 Days)
  • TXMD 113.1K
  • HUBC 2.2M
  • Earning Date
  • TXMD 03-28-2025
  • HUBC 12-13-2024
  • Dividend Yield
  • TXMD N/A
  • HUBC N/A
  • EPS Growth
  • TXMD N/A
  • HUBC N/A
  • EPS
  • TXMD N/A
  • HUBC N/A
  • Revenue
  • TXMD $1,596,000.00
  • HUBC $33,357,000.00
  • Revenue This Year
  • TXMD $605.07
  • HUBC N/A
  • Revenue Next Year
  • TXMD $1.11
  • HUBC N/A
  • P/E Ratio
  • TXMD N/A
  • HUBC N/A
  • Revenue Growth
  • TXMD N/A
  • HUBC N/A
  • 52 Week Low
  • TXMD $0.70
  • HUBC $0.37
  • 52 Week High
  • TXMD $2.75
  • HUBC $2.17
  • Technical
  • Relative Strength Index (RSI)
  • TXMD 41.47
  • HUBC 68.12
  • Support Level
  • TXMD $0.99
  • HUBC $0.70
  • Resistance Level
  • TXMD $1.13
  • HUBC $1.25
  • Average True Range (ATR)
  • TXMD 0.06
  • HUBC 0.15
  • MACD
  • TXMD -0.00
  • HUBC 0.04
  • Stochastic Oscillator
  • TXMD 5.26
  • HUBC 79.70

About TXMD TherapeuticsMD Inc.

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

About HUBC Hub Cyber Security Ltd.

Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.

Share on Social Networks: